Pharma Mar (XMAD:PHM) Quality Rank


XMAD:PHM Pharma Mar SA XMAD:PHM
83 GF Score
Price €78.80
GF Value €82.14
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Pharma Mar Quality Rank Related Terms

XMAD:PHM
83GF Score
Pharma Mar SA XMAD:PHM
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharma Mar (XMAD:PHM) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of €78.80 is trading 4.1% below its estimated GF Value™ of €82.14. GuruFocus considers Pharma Mar to be Fairly Valued.

Key valuation signals for XMAD:PHM:

  • Quality Rank:
  • GF Value™: €82.14 vs. price of €78.80 (4.1% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the XMAD:PHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
83GF Score

Get the complete analysis for XMAD:PHM

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.80
Price
€82.14
GF Value